Yann (ME/LC)

Yann (ME/LC)

me-cfs.bsky.social

Disabled by very Severe Post-COVID ME/CFS. Not always able to use phone. Bedridden. Unable to Speak. I care. Ⓐ💚, (FR/DE/EN, but posts in english) Clinging onto the ledge above the abyss.

👤 Joined on 17 May 2024

1744

Followers

778

Following

1760

Total Posts

📜 Kullanıcı Geçmişi

  • 17 May 2024, 18:58
    🎉 Bluesky'e katıldı - İlk kullanıcı adı: @me-cfs.bsky.social

❤️ Beğendiği Gönderiler

📢 #ApplyNow: GDPR Litigation lawyer! Applications are open until tomorrow, 21.10.2026. 📢 ▸ Workplace: #Vienna ▸ Home and remote office (50-75% office presence) ▸ Working language: English ▸ Part-/Full-time (20-40h) For more information, visit 👉 noyb.eu/en/gdpr-liti...

Show Post

@retractionwatch.com it’s 15 yrs since the fraudulent PACE trial & yet no retraction. @davetuller1.bsky.social & @georgemonbiot.bsky.social acknowledge this as the #GreatestMEdicalScandal It has contributed to the death & destruction of many lives. Pls could you highlight the continued injustice?

Show Post

This is what Sir Simon Wessely described to Julie Rehmeyer as "OK folks, nothing to see here, move along please." #PACEtrial protocol changes which inflated recovery rates by several times and turned null results into success for CBT and GET. #MECFS web.archive.org/web/20230606...

Show Post
ME/CFS Science
20 October 2026 13:55

18) Link to the preprint (not yet peer-reviewed): Painter et al. 2026. Persistently activated virus-specific CD8 T cells indicate antigen-driven immune aberrations in long COVID. www.biorxiv.org/content/10.6...

Show Post
ME/CFS Science
20 October 2026 13:55

17) Overall, it’s an impressive paper that will likely receive more follow-up. The authors argue that these markers help to stratify participants in treatment trials to identify those most likely to benefit from interventions targeting SARS-CoV-2 persistence or EBV reactivation.

Show Post

Select language

Install App

Install App